Status:
COMPLETED
Influence of Opioids on Circulating Tumor Cells in Radical Cystectomy
Lead Sponsor:
RenJi Hospital
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Multiple lines of evidence have shown that perioperative opioids requirement was associated with poor outcomes in cancer patients, including increased cancer progression and metastases and reduced sur...
Eligibility Criteria
Inclusion
- Age \>=18
- ASA I-II
- Patients with primary bladder cancer of Stage T2a or higher, who are scheduled for robot-assisted laparoscopic radical cystectomy
- Written informed consent
Exclusion
- Emergency surgery
- Palliative surgery
- Contraindications for epidural anesthesia
- Metastatic bladder cancer
- Patients with a history of any other malignancy
- Chronic opioids medication
- severe systemic disease (heart, lung, kidney, or immune system)
- Known hypersensitivity or suspected allergy to intervention drugs
- Intellectual Disability
Key Trial Info
Start Date :
June 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 21 2021
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04358718
Start Date
June 2 2020
End Date
January 21 2021
Last Update
August 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji hospital, School of Medicine, Shanghai Jiaotong University
Shanghai, Shanghai Municipality, China, 200127